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Abstract: This study aimed to investigate the potential cytotoxic effects and phenolic contents of aqueous (HTS) and methanolic (HTM)
extracts of Holothuria tubulosa gathered from Muğla (Turkey) against different cancer cells for the first time. An MTT assay was carried
out to determine cellular viability. Apoptotic cell death was determined using flow cytometry. DNA fragmentation assay and caspase-3
activity analysis were carried out. Both extracts were analyzed by high performance liquid chromatography (HPLC) for quantification
of phenolic compounds. Both HTS and HTM extracts generally caused a decrease in the cell viability in a concentration- and timedependent manner. The lowest IC50 value was found in the HeLa cell line with 21.01 µg/mL for the HTS extract at 72 h. Both extracts
are capable of significantly enhancing the apoptotic process in HeLa and A549 cells, causing DNA fragmentation, and also increasing
activity of caspase-3 in both these cell lines, especially after treatment with at 500 µg/mL. Based on HPLC analysis, the most abundant
component was epicatechin (790.091 µg/g extract) and 2.5 dihydroxybenzoic acid (153.890 µg/g extract) in the HTS and HTM extracts,
respectively. This is the first study showing potential cytotoxic activity of H. tubulosa extracts from Muğla, Turkey against human cancer
cells. Our results suggest that H. tubulosa may be a good source for development of anticancer agents.
Key word: Holothuria tubulosa, cancer cell lines, cytotoxicity, apoptosis, HPLC analysis

1. Introduction
Cancer remains one of the most significant causes of
death worldwide, resulting in the morbidity and mortality
of millions of people [1]. Most currently available drugs
have the potential to display toxic side effects without
cell selectivity for cancer cells [2]. Moreover, resistance to
chemotherapeutic drugs may develop in cancer cells [3].
Therefore, studies for determination of new anticancer
agents that can selectively kill malignant tumor cells remain
important [4]. Additionally, an optimal anticancer agent is
also expected to delay or reverse cancer development [5].
Phenolic compounds, widespread in plant-based foods,
are known to function as antioxidants. They are capable of
contributing to the scavenging of free superoxide radicals,
reducing the risk of cancer, and also protecting vital
biomolecules such as proteins, lipids, and DNA from the
damaging effects of oxidative processes [6].
Most (~60%) approved drugs for cancer treatment
originate from natural products. Marine organisms make
up about half of the total species diversity on the earth.
The marine ecosystem is a significant source for discovery
of useful therapeutic agents [7], and marine environments
contain numerous species possessing a wide range of novel

bioactive secondary metabolites [8]. Natural compounds
from marine sources may exhibit various bioactive
properties such as antitumor, anticancer, antimicrotubule,
antiproliferative, antihypertensive, and cytotoxic effects
[9]. Currently, roughly 28,600 natural products have been
reported to originate from various marine sources [10].
Sea cucumbers (or holothurians) are classified as
echinoderms (phylum Echinodermata) and belong to
the class Holothuroidea. They are a group of marine
invertebrates found in benthic areas and deep seas that
usually have leathery skin and an elongated body which is
soft and looks like a cucumber. Sea cucumbers, also known
as trepang, bêche-de-mer, balate or haishen (ginseng of
the sea), are used as food and in Asian folk medicine [11].
The various biological and pharmacological benefits of sea
cucumbers such as their anticoagulant, antithrombotic,
antioxidant, anticancer, and antimicrobial properties
were reviewed by Bordbar et al. [12] and Khotimchenko
[13]. Because sea cucumbers have nutritional, health
and possibly therapeutic value, they have attracted
the attention of scientists in recent decades [13]. The
compounds responsible for the biological activities of sea
cucumbers have been reported to be chondroitin sulfate,
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glycosaminoglycans, peptides, and other secondary
metabolites, as well as triterpene glycosides called saponin
[12,14].
Sea cucumbers have been exported from Turkey since
1996. One main commercial species in Turkey is Holothuria
tubulosa (Gmelin, 1791) [15]. Biodiversity is largely
threatened by global warming and other environmental
causes. As a result, it is important to investigate local natural
sources in detail for possible use in the development of
drugs [16]. To our knowledge, there is a lack of information
about the potential anticancer properties of H. tubulosa in
the literature, although there are different studies related
to its population, reproduction, and biometric traits
[15,17]; cytotoxic activity [18], antiinflammatory activity
[19], antioxidant, and antimicrobial activity [20]; immune
mediators [21], proximate composition, and fatty acid
profile [22]. Therefore, the aim of this study is to evaluate
the potential cytotoxic and apoptotic effects of aqueous
(HTS) and methanolic (HTM) extracts of H. tubulosa from
Muğla, Turkey on different human cancer cell lines, as well
as determining the phenolic compounds in the extracts by
high performance liquid chromatography (HPLC).
2. Materials and methods
2.1. Collection of and extract preparation from H.
tubulosa
H. tubulosa specimens were collected from the Gökova
Gulf in Muğla, Turkey and transported to the laboratory.
The internal organs of the sea cucumbers were immediately
removed. After washing their remaining parts with tap
water and then deionized water, the sea cucumbers’ bodies
were stored at –80 °C or extracted. For extraction, the sea
cucumber samples were sliced, dried, and minced into
small pieces. Approximately 10 g of each minced sample
was extracted with 100 mL of deionized water or methanol
(Merck, USA) and shaken at 30 °C for 8 h at least 3 times
and then filtered. The methanol used as a solvent was
removed by rotary evaporation (IKA, RV 10, USA) at 40
°C. Finally, after the lyophilization process, each crude
extract (HTS or HTM extract) that was obtained was kept
at –80 °C in the dark. The stock solution of each crude
extract was prepared by suspending it in growth medium
containing 10% DMSO.
2.2. Cell cultures for human cancer and normal cell lines
All cell lines used in this study were obtained from ATCC.
These cells were A549 (lung adenocarcinoma), HeLa (cervix
adenocarcinoma), MCF-7 (breast adenocarcinoma), PC-3
(prostate adenocarcinoma) human cancer cell lines,
HEK293 (normal human embryonic kidney), and BEAS2B (normal bronchial epithelium) cell lines. The cell lines
were cultured in an RPMI-1640 medium with stable
L-glutamine (Biochrom, Germany), 10% heat inactivated
fetal bovine serum (FBS) (Biochrom, Germany), 100
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units/mL penicillin, and 100 µg/mL streptomycin sulphate
(Biochrom, Germany) and incubated at 37 °C under a
humidified atmosphere of 5% CO2.

2.3. MTT assay
The effects of the extracts on cell viability were assessed
based on an MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5diphenyl-2H-tetrazolium Bromide) assay [23]. The cell
lines were seeded at a concentration of 4 × 103 cells/well
in 96-well plates and allowed to attach for 24 h. The cells
used were then treated with the HTS or HTM extract of H.
tubulosa at 8 different concentrations (1000–7.8 µg/mL) for
24, 48, and 72 h. The untreated cells were used as a control
group. At the end of the treatment periods, the medium
with the extract in each well was replaced with 100 mL
of fresh growth medium. The cells were later incubated
with 10 μL of 5 mg/mL MTT reagent (Applichem, USA)
in phosphate-buffered saline (PBS) for 4 h. After removing
the contents of each well, 100 mL of DMSO was added
to dissolve the purple crystals of formazan formed in
the viable cells. Finally, absorbance (Abs) was measured
by a microplate reader (Thermo Scientific, Multiskan
FC, USA) at 540 nm. Because the serial dilutions were
prepared in growth medium from stock solutions, the final
concentration of DMSO in the tested cells was no more
than 0.1%. Each MTT assay was performed in triplicates at
least 2 times. The percent of the cell viability was calculated
according to the following formula:
Cell viability % = (Mean Abs of treated cells / Mean
Abs of control or untreated cells) x 100.
In this study, the degree of selectivity of the cytotoxic
extracts was expressed as selectivity index (SI) = IC50
in normal cells/IC50 in cancer cells, according to the
information reported in a previous study [24].
2.4. Analysis of apoptotic cells
The percentage of apoptosis in the treated (A549 and
HeLa) and control cells were determined by Annexin
V-FITC/propidium iodide staining using flow cytometry,
according to the instructions of the Annexin V-FITC
Apoptosis Detection Kit (eBioscience, USA) protocol. The
cells with a density of 5 × 105 cells/well were cultured in
6-well plates and incubated for 24 h. After treatment with
the HTS or HTM extract at various concentrations (500,
250, and 125 µg/mL) for 24 and 48 h (and 72 h for A549
cells only), cell suspensions were harvested and washed
twice with cold PBS. The cells were then resuspended in
190 μL binding buffer and incubated with 5 μL Annexin
V-FITC at room temperature for 10 min in the dark. After
centrifugation, the cells were again dissolved in 190 µL
binding buffer and stained with 10 μL propidium iodine
at 20 μg/mL at room temperature in the dark. Finally, the
cells in each group were evaluated by BD FACSCanto flow
cytometry (BD Biosciences, San Jose, CA, USA) using
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the BD FACSDiva software v6.13. The control cells were
untreated cells.
2.5. DNA fragmentation assay
DNA extraction was performed based on the procedure
described by Gong et al. [25] with modification. The A549
and HeLa cell lines were cultured in 6 mL of growth medium
in 25 cm2 cell culture flasks at a concentration of 7.5 × 104
cells for 24 h. The cells were then treated with the HTS or
HTM extract at 500, 250, and 125 µg/mL concentrations
for 36 h. The untreated cells were used as a control group.
After this, the cells were harvested by scraping and washed
with DPBS. The cells were later prefixed in 70% ethanol
at –20 °C for 24 to 72 h. After centrifugation, the ethanol
was thoroughly removed, and each pellet was extracted
with 50 µL of phosphate-citrate buffer at pH 7.8 and 37
°C for 30 min. After centrifugation, the supernatant, at a
volume of about 40 µL, was collected and incubated with
5 µL RNase (20 mg/mL) and 5 µL Tween 20 at 37 °C for
30 min. Following this, proteinase K (20 mg/mL) was
added and incubated additionally for 30 min at 37 °C. For
DNA fragmentation analysis, the DNA was subjected to
electrophoresis at 80–100 V in 1.5% agarose gel stained
with ethidium bromide and finally visualized by a UV
transilluminator (Vilber Lourmat, France).
2.6. Caspase-3 activity assay
Caspase-3 activity was detected using a colorimetric
assay kit (Abcam, Cambridge, UK) according to the
manufacturer’s protocol. The A549 and HeLa cells were
plated at 2 × 106 cells/well in 6-well plates. After 24 h of
incubation, the cells were treated with the HTS or HTM
extract at various concentrations (500, 250, and 125 µg/mL)
for 36 h. At the end of the incubation time, the cells were
collected, resuspended in 50 µL of cold cell lysis buffer, and
incubated on ice for 10 min. After centrifuging at 10,000 g
for 1 min, the protein concentration of each cell lysate was
determined by Bradford’s method [26]. Approximately 50
µL of 2X reaction buffer containing 10 mM DTT and 5 µL
of caspase-3 substrate (4 mM DEVD-p-NA) was added to
each sample containing 200 µg of protein and incubated
at 37 °C for 2 h. The absorbance of p-NA was measured
at 405 nm in a microplate reader. The caspase-3 activity
of untreated cells was determined as 1.0, and data related
to caspase-3 activity was expressed as a fold-increase by
comparing them to that of the untreated cells.
2.7. Analysis of phenolic compounds by HPLC
Phenolic compounds of the HTS and HTM extracts were
analyzed by HPLC (Shimadzu Scientific Instruments,
Kyoto, Japan) according to method described by Caponio
et al. [27] with a slight modification. The analysis was
performed with a photodiode array detector (SPDM20A), LC20 AT pump, and a SIL-20ACHT auto sampler.
The separation was carried out using the C18-column

with a CTO-10ASVp column oven. The mobile phases
were solvent A: 3.0% formic acid in distilled water and
solvent B: methanol. Each sample of 0.2 g was dissolved in
a mobile phase and filtered through a 0.45-μm filter before
injection into the HPLC. Gallic acid, 3.4-dihydroxybenzoic
acid, 4-hydroxybenzoic acid, 2.5 dihydroxybenzoic acid,
chlorogenic acid, vanillic acid, epicatechin, caffeic acid,
p-coumaric acid, ferulic acid, rutin, ellagic acid, naringin,
cinnamic acid, and quercetin were used as standards.
Differentiation and quantitative analysis were based on
comparison of the standards. The amount of each phenolic
compound was expressed as μg/g per gram of the extract.
2.8. Statistical analysis
All calculation of the IC50 values were carried out using the
GraphPad Prism software version 7.0 (GraphPad Software
Inc., San Diego, CA, USA).
3. Results
3.1. The cytotoxic effects of H. tubulosa extracts on
different cell lines
An MTT assay was used to assess the potential cytotoxic
effects of the extracts against human cancer (A549, HeLa,
PC-3 and MCF-7) and normal cell lines (HEK293 and
BEAS-2B). According to our results, it may be suggested
that the HTS and HTM extracts caused a concentrationand time-dependent decrease in cell viability in comparison
to the control groups (Figure 1). Cell proliferation of the
tested cancer cells was markedly inhibited by the HTS and
HTM extracts between concentrations of 250 and 1000 µg/
mL after 24, 48, and 72 h of treatment. The approximate
50% inhibitory concentration (IC50) of both extracts for all
cells that were used and SI values are summarized in Table
1 and Table 2, respectively. The lowest IC50 values among
all cancer cells at 72 h were 21.01 µg/mL in the HeLa cells
for the HTS extract and 63.12 µg/mL in the A549 cells for
the HTM extract.
Based on the IC50 values, it may be stated that the
HTS extract showed a higher cytotoxic effect against all
cancer cell lines tested at 24 and 48 h in comparison to
normal cell lines. Likewise, the HTM extract at 24 and 48
h had a higher cytotoxic effect against the A549 and HeLa
cancer cells than the other cancer and normal cell lines.
Furthermore, SI values were calculated by comparing the
IC50 values of the extracts in the normal cell lines to the
IC50 values of the same extracts in the cancer cell lines. As
Nguyen and Ho-Huynh [24] stated, an SI value above 2 is
considered cytotoxic selectivity. As shown in Table 2, the
HTS extract showed the best SI values against the A549
cell line (4.12 and 3.48, respectively) for 48 h versus both
the HEK293 and the BEAS-2B cell lines and against the
HeLa cell line (2.85) for 72 h versus the BEAS-2B cell lines.
Additionally, the best SI value determined for the HTM
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Figure 1. Cell viability of the cells after exposure to HTS (A) and HTM (B) extracts on different human cancer
and normal cells. A549 (a), HeLa (b), PC-3 (c), MCF-7 (d), HEK293 (e), BEAS-2B (f) cells were treated with
the HTS or HTM extract in a concentration and time dependent manner. Cell viability was evaluated by MTT
assay. Data was expressed as mean ± standard error of 3 separate experiments.

extract was against the HeLa (2.61) for 48 h versus the
HEK293 cell line. Altogether, these results demonstrated
that both extracts may be tested to obtain promising
anticancer agents.
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3.2. The effects of H. tubulosa extracts on apoptosis
The HTS and HTM extracts exhibited more cytotoxicity
on the A549 and HeLa cells in general. As a result, the
effects of both extracts on apoptosis were investigated by
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Figure 1. (Continued).

flow cytometry using AnnexinV/PI double staining in
these 2 cell lines. As shown in Figure 2A(a), treatment
of A549 cells with 500, 250, and 125 µg/mL of the HTS
extract for 48 and 72 h resulted in a significant increase
in the percentages of apoptosis (quadrants 2 and 4) and
reduced the percentages of the viable cells (quadrant 3) in
comparison to the control. The percentages of apoptotic
A549 cells at 48 h were increased from 3.6% (control) to
42.2%, 36.8%, and 35.7% for 500, 250, and 125 µg/mL

concentrations of the HTS extract, respectively. After
treatment with 500, 250, and 125 µg/mL concentrations of
the HTS extract for 72 h, the percentages of the apoptotic
A549 cells were 45.2%, 48.7%, and 47.7%, respectively, in
comparison to the control group (8%). As shown in Figure
2A(b), treatment with 500 µg/mL of the HTM extract
altered the percentages of the apoptotic A549 cells from
20% (control) to 56.1% for 24 h and from 8% (control) to
47.4% for 72 h. Furthermore, the HTM extract at 500 µg/
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Table 1. Cytotoxic effects of (approximate IC50 value) H. tubulosa extracts on A549,
HeLa, PC-3, MCF-7, HEK293, and BEAS-2B human cell lines.
IC50 (µg/mL)
Cells

HTS extract

HTM extract

24 h

48 h

72 h

24 h

48 h

72 h

A549

229.5

112.8

53.95

200.3

157.1

63.12

HeLa

238.3

180.2

21.01

146.4

83.73

83.32

PC-3

282.6

177.2

166.6

282.3

257.2

70.03

MCF-7

228.5

176.7

36.15

267.6

221.5

179.6

HEK293

479

464.4

28.11

226.4

218.2

59.47

BEAS-2B

413.5

393.05

59.80

241.15

168.9

68.19

Table 2. Selectivity index (SI) values of the H. tubulosa extracts.
SI*
HTS extract

Cells

A549
HeLa
PC-3
MCF-7

HTM extract

24 h

48 h

72 h

24 h

48 h

72 h

vs HEK293

2.08

4.12

0.52

1.13

1.38

0.94

vs BEAS-2B

1.8

3.48

1.10

1.20

1.07

1.08

vs HEK293

2.01

2.57

1.33

1.54

2.61

0.72

vs BEAS-2B

1.73

2.18

2.85

1.64

2.01

0.81

vs HEK293

1.69

2.62

0.16

0.80

0.84

0.84

vs BEAS-2B

1.46

2.21

0.35

0.85

0.65

0.97

vs HEK293

2.09

2.62

0.77

0.84

0.98

0.33

vs BEAS-2B

1.8

2.22

1.65

0.90

0.76

0.37

*SI values determined for A549, HeLa, PC-3, and MCF-7 cancer cells versus normal HEK293 and BEAS2B cell lines. The numbers in bold were expressed as important SI values.

mL caused the most significant increase in the apoptotic
A549 cells (90%) in comparison to control (3.6%) at 48 h.
However, the HTM extract at concentrations of 250 and
125 µg/mL resulted in less apoptosis in the A549 cells than
the HTS extract at the same concentration for 48 and 72 h.
Additionally, our results showed that the apoptotic cells in
the treated A549 cells for 48 h belonged predominantly to
those in a late stage of apoptosis.
Since the percentages of the necrotic cells were
generally increased after 72 h of treatment, the flow
cytometry analysis of the HeLa cells was carried out
for only 24 and 48 h. The HTS extract generally caused
increased apoptotic effects against the HeLa cells in a
time-dependent manner as in the A549 cells (Figure
2B). After exposure to 500 µg/mL of the HTS extract,
the apoptosis rate in the HeLa cells increased from

646

10.5% in the control to 25.9% for 24 h and from 7.3%
(control) to 44.3% for 48 h. Additionally, the percentages
of the apoptotic HeLa cells treated with 250 µg/mL of
the HTS extract were 19.7% and 50.2% for 24 and 48 h,
respectively. The HTS extract at 125 µg/mL also induced
a higher apoptosis rate in the HeLa cells at 48 h (44.3%)
than at 24 h. As shown in Figure 2B(b), the HTM extract
induced apoptosis in 31.6% and 49.6% of the HeLa cells
exposed to 500 µg/mL for 24 and 48 h, respectively. The
HTM extract at concentrations of 250 and 125 µg/mL did
not cause a notable increase in the percentage of apoptotic
HeLa cells for 24 and 48 h in comparison to the control
groups. As observed in the A549 cells, the apoptotic cells
among the HeLa cells treated for 48 h were found to be in
the late stage of apoptosis. These findings may show that
H. tubulosa has cytotoxic properties.
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Figure 2. Flow cytometry analysis of apoptosis in A549 (A) and HeLa (B) cells treated with HTS (a) or HTM (b) extract. Cells were
separately treated with each extract at 500, 250, and 125 µg/mL at different incubation times. Annexin V/PI double-staining assay was
carried out and cells were analyzed by flow cytometry. Untreated cells served as control. Cells were distributed into 4 quadrants: viable
cells (Q3), early apoptotic cells (Q4), late apoptotic cells (Q2), and necrotic cells (Q1).
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Figure 2. (Continued).

3.3. Determination of DNA fragmentation in treated
cells with H. tubulosa extracts
DNA fragmentation assay was also carried out to confirm
the induction of apoptosis arising from the HTS and HTM
extracts. After treatment for 36 h, DNA fragmentation
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known as the characteristic of apoptosis [28] was observed
on the A549 and HeLa cells. The prominent DNA ladder was
found in the A549 cells treated with 250 µg/mL of the HTS or
HTM extract (Figure 3). Therefore, these results confirmed
that the HTS and HTM extracts may induce apoptosis.
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Figure 2. (Continued).

3.4. The effects of H. tubulosa extracts on caspase-3
activity
Caspase-3 activities in the treated and untreated cells
were analyzed using an in vitro colorimetric substrate
DEVD-pNA. The results shown in Figure 4A reveal that
the HTS extract at 500 µg/mL caused about 6.7-fold and
7-fold increases in the caspase-3 activity in the A549 and
HeLa cells, respectively, in comparison to the untreated
cells. Moreover, after being treated with 500 µg/mL of the
HTM extract (Figure 4B), the caspase-3 activity in the
A549 and HeLa cells was respectively about 7.6-fold and
6-fold higher than those in the untreated cells. Another
significant caspase-3 activity, which was approximately

a 2.8-fold increase in comparison to the untreated cells,
was detected in the HeLa cells exposed to the 250-µg/
mL concentration of the HTS extract. These data help
to confirm the results obtained from the analysis of flow
cytometry and DNA fragmentation.
3.5. Phenolic composition in H. tubulosa extracts
The phenolic compounds and quantities were
characterized by HPLC using 15 standards from the HTS
and HTM extracts, as shown in Table 3. According to this
analysis, 13 and 12 phenolic compounds were determined
in the HTS and HTM extracts, respectively. The main
phenolic compounds in the HTS extract were detected as
epicatechin (790.091 µg/g extract), ellagic acid (558.671
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Figure 3. DNA fragmentation of A549 (A) and HeLa (B) cells exposed to H. tubulosa extracts. The cells were treated with
increasing concentrations of HTM (2–4) or HTS (6–8) extracts of 125, 250, and 500 µg/mL, respectively. M: Marker 1kb DNA
Ladder, 1 and 5: control (untreated cells).

HTM 500 μg/mL
HTM 250 μg/mL
HTM 125 μg/mL

Figure 4. Measurement of caspase-3 activity in HTS (A) or HTM (B) treated A549 and HeLa cells. The caspase-3 activities in
control (untreated) cells are taken as 1-fold and other activities were presented by comparing with the control cells. Data was
expressed as mean ± standard error of 3 separate experiments.

µg/g extract), gallic acid (205.871 µg/g extract), and 2.5
dihydroxybenzoic acid (130.541 µg/g extract)—all listed
based on their amounts. The HTM extract was also found
to be rich in 2.5 dihydroxybenzoic acid (153.890 µg/g
extract), gallic acid (133.169 µg/g extract), and ellagic acid
(109.258 µg/g extract), except for epicatechin (0.726 µg/g
extract). p-coumaric acid was found in the HTS extract
(78.475 µg/g extract), but it was not seen in the HTM
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extract. Cinnamic acid was assessed as a minor compound
for both extracts. Neither rutin nor quercetin was found
in the extracts.
4. Discussion
Sea cucumbers are reportedly used as foods and as a
traditional remedy for treating various diseases in various
countries such as Korea, Japan, China, Malaysia, and
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Table 3. HPLC analysis of HTS and HTM extracts for phenolic compounds.
No.

Phenolic Compounds

RT
(min)

UVmax
(nm)

HTS
(μg/g extract )

HTM
(μg/g extract )

1

Gallic acid

6.8

280

205.871

133.169

2

3,4-dihydroxybenzoic acid

10.7

280

28.264

4.699

3

4-hydroxybenzoic acid

15.7

280

11.171

15.464

4

2,5-dihydroxybenzoic acid

17.2

320

130.541

158.890

5

Chlorogenic acid

18.2

320

5.638

11.91

6

Vanillic acid

19.2

320

3.423

7.483

7

Epicatechin

21.3

260

790.091

0.726

8

Caffeic acid

22.7

280

8.369

8.594

9

p-coumaric acid

26.1

320

78.475

-

10

Ferulic acid

30.1

320

0.391

0.208

11

Rutin

45.6

360

-

-

12

Ellagic acid

47.7

240

558.671

109.258

13

Naringin

49.7

280

0.387

0.379

14

Cinnamic acid

67.8

280

0.013

0.013

15

Quercetin

71.1

360

-

-

RT: retention time.

Indonesia [29]. Because of the bioactive compounds they
carry, they continue to be considered as potential sources
of novel bioactive agents for the prevention and treatment
of various diseases [30–32]. There are several studies on
the cytotoxic effects of different sea cucumber species on
various cancer cell lines in the literature [33–36].
Our literature review shows that there is no previous
research-based evidence about the biological activities
related to the anticancer properties of 2 different extracts
of H. tubulosa growing in Turkey: HTS and HTM. Their
cytotoxic effects on 4 cancer cell lines (A549, HeLa,
MCF-7, and PC-3) and 2 normal cell lines (HEK293 and
BEAS-2B) were conducted in MTT assays at varying
concentrations and different time intervals. Following the
comparison of the IC50 values of both extracts at 24 and 48
h, it was observed that these are lower for HTS in all cancer
cell lines and for HTM in only A549 and HeLa cells than
in the 2 normal ones. The lowest IC50 values of the HTS
were calculated as 112.8 µg/mL for the A549 at 48 h and
21.01 µg/mL for the HeLa at 72 h. The highest cytotoxic
effect for HTM extract was determined in the HeLa cells
with IC50 value of 83.73 µg/mL at 48 h. SI values above 2
refer to the cytotoxic selectivity [24]; the highest SI values
for the HTS were detected in A549 cells at 48 h and Hela
cells at 72 h and those for the HTM in the HeLa at 48 h.
Unlike our study, Luparello et al. [18] showed that the total
and filtered HTS extracts of the coelomic fluid of Holoturia
tubulosa gathered from the Gulf of Palermo (Sicily, Italy)

are cytotoxic to TNBC (triple negative breast cancers)
cell line MDA-MB231. The authors also reported that
their study provided the first data linking cell exposure
to H. tubulosa-derived extracts to the event of autophagy
induction. In addition, there are various studies in the
literature on the cytotoxic effects of different Holothuria
species on cancer cells. Althunibat et al. [35] assessed
the inhibition effect of different sea cucumber extracts
(Holothuria scabra, Holothuria leucospilota, and Stichopus
chloronotus) on the growth of 2 cancer cell lines (A549
and C33A) and reported that the aqueous extract of S.
chloronotus was more toxic against C33A cells (IC50 = 10.0
μg/mL) than A549 (IC50 = 28.0 μg/mL). Among organic
extracts, H. scabra was found to be the one with the highest
antiproliferative effects against both A549 (IC50 = 15.5 μg/
mL) and C33A (IC50 = 3.0 μg/mL) cells. Furthermore, 3
triterpene glycosides (scabraside D, fuscocineroside C,
and 24-dehydroechinoside A) from H. scabra showed a
significant cytotoxic effect on P-388 (a mouse leukemic
cell), A549, MKN-28 (gastric cancer cell), HCT116 (human
colorectal cancer cell), and MCF-7 cells with IC50 values in
the range of 0.93–2.60 µmol/L [37]. Dhinakaran and Lipton
[38] displayed the antiproliferative effects of the methanol
extracts of H. atra against HeLa (IC50 = 468.0) and MCF-7
(IC50 = 352.0) cell lines. Another study demonstrated that
the novel active compound identified as nobiliside D from
H. nobilis exhibited inhibitory effects on K562 (human
leukemic), U937 (human leukemia), A549, HeLa, MCF‑7,
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and HepG2 (human liver carcinoma) cell lines [39]. Kareh
et al. [40] reported that the ethanolic extract and partially
purified aqueous fraction of H. polii significantly reduced
the proliferation of human mammary adenocarcinoma
cells (MDA-MB-231). These data supported the view
that sea cucumbers should be considered as sources of
anticancer agents, and the potential of their extracts may
be different according to the solvent chosen, the methods
followed, the cells tested, and also the species analyzed.
Cancer can occur when the balance between cell
division and cell death is disrupted and so there may be
an increase in cell proliferation and a decrease in cell death
[41]. Additionally, too little apoptosis has been known to
occur in cancer cells [42]. Induction of apoptosis, known
as a form of programmed cell death, is considered to be a
significant process in controlling the progression of cancer
during cancer treatment [43]. Here, the Annexin V-FITC/
PI assay was used to the detect the percentages of apoptotic
A549 and HeLa cells after treatment with the HTM and
HTS extracts at concentrations of 500, 250, and 125 µg/mL
for different incubation periods. Our results showed that
the HTS and HTM extracts were able to provide significant
enhancements in the rates of apoptotic cells. The late stage
of apoptosis was usually predominant at 48 h. The increase
in the percentage of necrotic cells in the course of time may
be due to the progression of apoptotic cells into secondary
necrotic cells. Secondary necrotic cells are cells that have
gone through various modifications during the process of
apoptosis [44]. Because of the lack of phagocytic capacity,
observation of secondary necrosis is frequently considered
as an in vitro artifact [45]. In a previous study, Baharara et
al. [46] stated that the aqueous extract of the sea cucumber
species H. arenicola from the Persian Gulf induced
apoptosis. Sangpairoj et al. [47] reported that the extract
of H. scabra induced apoptosis, loss of mitochondrial
membrane potentials, and nuclear condensation and
fragmentation. The novel active compound identified as
nobiliside D (at 0.5 μg/mL) from H. nobilis increased the
rate of apoptosis in K562 and MCF-7 cells in comparison
to control cells [39]. In another study, human breast ductal
carcinoma cell (T47D) populations were reported to have
undergone apoptosis after being treated with the ethanol
extract of H. atra [48]. However, for the first time, the
results in this study demonstrated that the mechanism
underlying the cytotoxicity of both the HTS and HTM
extracts may have involved induction of apoptosis in the
A549 and HeLa cells.
DNA fragmentation by endogenous DNases is
considered to be a hallmark of apoptosis. This may be
detected through agarose gel electrophoresis because DNA
fragmentation creates a ladder pattern with fragments of
180–200 base pairs in length [49,50]. Here, the apoptosis
in the highest concentration (500 µg/mL) may occur more
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rapidly, and this may explain why the DNA ladder might
not be seen. However, our results showed that, at 250 µg/
mL, the HTS and HTM extracts produced a typical DNA
ladder in the A549 cells. Furthermore, DNA fragmentation
was observed in the HeLa cells. These results supported
the expectation that both extracts were capable of causing
induction of apoptosis in the A549 and HeLa cells.
Caspase-3 is known to be one of the essential proteins
associated with the apoptotic process [51] and, thus, it may
be used as a marker for apoptosis. Our results indicated
the presence of the highest caspase-3 activity in the cells
(A549 and HeLa) treated with both extracts at 500 µg/
mL in comparison to the control groups. Additionally,
at 250 µg/mL, the HTS extract was found to have caused
relatively more caspase-3 activation than the HTM extract.
Nursid et al. [48] showed that the ethanol extract of H. atra
activated caspase-3 on T47D cells. In the melanoma cancer
cell line B16F10, the enzymatic activities of caspase-3 (as
an apoptosis inducer) and caspase-9 (as an apoptosis
effector) were reported to have increased among the
groups treated with sea cucumber extract from Holothuria
arenicola by Baharara et al. [52]. All of these findings
confirm that extracts from sea cucumbers are capable of
causing significant cytotoxicity on different cancer cell
lines through apoptosis.
Important results were presented about the effects
of phenolic compounds and their derivatives on cancer
treatment and prevention [53]. Finally, HPLC analysis
was performed to quantify the phenolic compounds in the
extracts. The most abundant phenolic compounds in both
the HTS and HTM extracts were detected as gallic acid,
2.5 dihydroxybenzoic acid, and ellagic acid. Remarkably,
epicatechin was determined at the highest levels in
the HTS extract, whereas it was only present in small
amounts in the HTM extract. Moreover, the amounts of
3.4 dihydroxybenzoic acid and ellagic acid were higher
in the HTS extract than in the HTM extract. p-coumaric
acid was only detected in the HTS extract. As noted in
different previous studies, the results of HPLC support the
fact that the types of solvents used can alter the content
and amounts of phenolic compounds according to their
polarity [54,55]. It was previously reported that gallic acid
has several important properties including antioxidant,
antiinflammatory, and antineoplastic activities and has
therapeutic effects for gastrointestinal, neuropsychological,
metabolic, and cardiovascular diseases [56]. Gentisic
acid or 2,5-dihydroxybenzoic acid was reported to have
various biological benefits such as antiinflammatory,
antirheumatic, and antioxidant effects [57], several
beneficial effects against heart attacks, atherogenesis,
and lipid hydroperoxide production and is able to inhibit
tumor growth as a fibroblast growth factor inhibitor [58].

ALPER and GÜNEŞ / Turk J Vet Anim Sci
Likewise, ellagic acid, a natural phenolic compound,
was reported to possess antioxidant, anticarcinogenic,
and antiinflammatory activity [59]. Epicatechin, with its
strong antioxidant properties, is a natural flavonoid and
has the potential for the treatment of diabetes and cancer
[60]. For this reason, our study suggested that the phenolic
compounds of the extracts might contribute to their
cytotoxic effects.
In conclusion, this is the first study to present the
potential cytotoxic properties of H. tubulosa from
Muğla, Turkey. Our results revealed that the aqueous and
methanolic extracts of this species are capable of causing
inhibition of the growth of cancer cell lines and of inducing
apoptosis in A549 and HeLa cells. The HTS extract, in which
epicatechin and ellagic acid were especially abundant, was
rich in the contents and amounts of phenolic compounds
associated with bioactivity in comparison to the HTM
extract. Our study provides new details on the evaluation
of H. tubulosa as a promising source for natural anticancer
agents. Further studies may determine the biologically
effective compounds from these extracts and explain the
involvement of these compounds in cancer treatment. Our

studies can also be supported with different extracts of H.
tubulosa.
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